01 1GLAXO GRP ENGLAND
02 3GLAXOSMITHKLINE
01 48309572
01 4Blank
01 4Blank
01 42025-04-27
Patent Expiration Date : 2025-04-27
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 203975
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-04-27
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 205382
Patent Use Code : U-1476
Delist Requested :
Patent Use Description : INDICATED FOR THE LONG...
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-04-27
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-2129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-27
Patent Expiration Date : 2025-04-27
FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE
US Patent Number : 8309572
Drug Substance Claim :
Drug Product Claim :
Application Number : 209482
Patent Use Code : U-2129
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-04-27
